Business

Fermenta Biotech Limited exclusively licenses the proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical Services Ltd

New Delhi (India), January 21: Fermenta Biotech Limited (FBL) today announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a stepdown subsidiary of Dr Reddy’s Laboratories Limited (DRL). In this arrangement, FBL will exclusively license its proprietary biocatalytic technology for the synthesis of Molnupiravir and supply its enzyme Candida Antarctica B Lipase (CAL B) to APSL, and APSL will exclusively procure the enzyme from FBL. Molnupiravir API manufactured by APSL will be utilized by DRL for its formulation. Additionally, APSL can also supply the API manufactured through this technology to other formulators of Molnupiravir, a COVID-19 drug that has recently received emergency use approval from the Food and Drugs Authority and Drugs Controller General of India.

This development follows FBL’s announcement of filing patents for its novel technology for synthesizing Molnupiravir in April 2021. Subsequently, the process has been further optimized at the laboratory scale, with demonstrations being successfully conducted at APSL’s R&D center in Hyderabad. FBL’s biocatalytic technology possesses unique advantages such as enzyme recyclability, optimum solvent recovery and improved process efficiency.

Prashant Nagre, Managing Director, FBL, commented, “Our technology, based on green chemistry, is one of the first of its kind in the world, enabling sustainable and scalable manufacture of Molnupiravir. Additionally, through our expertise in enzymatic solutions, we also bring in cost efficiency by leveraging our in-house enzyme. We are proud to play a role in our collective fight against COVID-19 by making this drug more affordable.”

Founded in 1951 and headquartered in Thane, Maharashtra, Fermenta Biotech Limited (FBL) is a pioneer in immobilized enzyme technology with the mission to contribute to the emerging transformation of Biocatalysis.

The enzyme manufacturing unit in Kullu, Himachal Pradesh and the Department of Biotechnology (DBT) approved R&D facility in Thane have consistently developed and sustained FBL’s leadership in providing advanced enzyme technologies. FBL is a pioneer in the development and production of fermentation-based Penicillin G Amidase enzyme (PGA) and commercialized immobilized enzymes in India. Further, FBL also manufactures CAL B Lipase for a variety of applications from pharmaceuticals, fine chemicals, food and fragrance, leather as well as biodiesel industry. Additionally, FBL is one of the leading manufacturers of Vitamin D3 globally. For more information about the Company and its businesses, please visit our website www.fermentabiotech.com

15 Replies to “Fermenta Biotech Limited exclusively licenses the proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical Services Ltd

  1. Fantastic goods from you, man. I’ve understand your stuff previous to and you are just too great. I actually like what you have acquired here, really like what you’re saying and the way in which you say it. You make it entertaining and you still take care of to keep it wise. I can’t wait to read far more from you. This is actually a wonderful site.

  2. A large percentage of of whatever you claim happens to be astonishingly accurate and it makes me ponder the reason why I had not looked at this in this light before. This particular piece really did turn the light on for me personally as far as this particular subject goes. However there is one particular position I am not necessarily too comfy with and while I make an effort to reconcile that with the actual core theme of the point, allow me observe exactly what the rest of the readers have to point out.Well done.

  3. Wow that was odd. I just wrote an very long comment but after I clicked submit my comment didn’t appear. Grrrr… well I’m not writing all that over again. Anyhow, just wanted to say fantastic blog!

  4. I wanted to make a simple message to appreciate you for all the fantastic suggestions you are sharing here. My time consuming internet research has at the end been recognized with wonderful insight to go over with my visitors. I would admit that most of us visitors actually are really blessed to dwell in a notable network with very many wonderful professionals with great principles. I feel really grateful to have encountered your web page and look forward to really more excellent moments reading here. Thank you once more for all the details.

  5. I carry on listening to the news bulletin lecture about getting boundless online grant applications so I have been looking around for the best site to get one. Could you tell me please, where could i get some?

Leave a Reply

Your email address will not be published.